Skip to content
akaturk Academic measurement
Search

Article detail · 2025 · article

Molecular investigations on T cell subsets in patients affected by hypomorphic DCLRE1C mutation

ISSN1744-666X
YÖKSİS OpenAlex Open access · green
Year2025
Citations2OpenAlex
Percentile%51.7
FWCI0.31.00 = world average
Scopus (SJR)Q2
WoS (JCR)Q2

Data source split

  • YÖKSİSYÖKSİS article record
  • YÖKSİS venueExpert Review of Clinical Immunology
  • Catalog match (ISSN)Expert Review of Clinical Immunology
  • OpenAlexOpenAlex enrichment (abstract, citations, topics)
  • Semantic Scholarcitation count (not merged with OpenAlex)

Abstract

OpenAlex English

Objective In this study, we explored the expression of transcription factors, cytokines, and co-stimulatory molecules within the helper T (Th) cell subsets (Th1, Th2, Th17, and Treg) of patients with hypomorphic DCLRE1C gene mutations.Methods The study comprised eight patients and five controls. Transcription factor and cytokine expressions of Th subsets and co-stimulatory molecules were investigated by qPCR and flow cytometric following T cell stimulation. The findings were compared between patients (non-HSCT) and with hematopoietic stem cell transplantation (HSCT).Results Flow cytometric analyses; while the Treg rate was significantly lower in non-HSCT than in controls (p = 0.010), the IFN-γ rate was significantly higher in patients than in the control and HSCT groups (p = 0.016, p = 0.022, respectively). Co-stimulatory molecule expressions were significantly lower in non-HSCT than in control (p < 0.001), and there was a significant improvement after HSCT. Post-stimulation qPCR analysis, significant changes were detected in non-HSCT/control, non-HSCT/HSCT, and HSCT/control comparisons.Conclusions Our study is the first study to molecularly investigate Th cell subsets in hypomorphic DCLRE1C patients. It was determined that abnormalities in Th cell subsets still persisted despite HSCT. There are still many conditions to be explained in these patients, and we believe that our study may shed light on future studies.

Topics

Citations

OpenAlex cited_by_count. Not a WoS or Scopus citation count; those sources have no separate column here.

2citationsOpenAlex · cited_by_count (cache / database)

5 publications in the local catalog that cite this work (OpenAlex reference match; not the full global list).

  1. 2026 A Novel Pathogenic Variant in TRAC Gene Associated with SCID Phenotype: Expanding the Genetic and Clinical SpectrumCitations 1 · OpenAlex
  2. 2026 CRISPR-Cas9–based gene editing as a proof-of-concept approach in an inborn error of immunity caused by a DCLRE1C variantCitations 1 · OpenAlex
  3. 2026 CRISPR-Cas9–based gene editing as a proof-of-concept approach in an inborn error of immunity caused by a DCLRE1C variantCitations 1 · OpenAlex
  4. 2026 CRISPR-Cas9–based gene editing as a proof-of-concept approach in an inborn error of immunity caused by a DCLRE1C variantCitations 1 · OpenAlex
  5. 2026 A Novel Pathogenic Variant in TRAC Gene Associated with SCID Phenotype: Expanding the Genetic and Clinical SpectrumCitations 0 · OpenAlex

Authors

9
  1. MEHMET ALİ KARASELEK NECMETTİN ERBAKAN ÜNİVERSİTESİ 1
  2. TUĞÇE DURAN 2
  3. SERKAN KÜÇÇÜKTÜRK 3
  4. ESRA HAZAR ALANYA ALAADDİN KEYKUBAT ÜNİVERSİTESİ 4
  5. ÖZNUR DOĞAR 5
  6. AYÇA KIYKIM İSTANBUL ÜNİVERSİTESİ-CERRAHPAŞA 6
  7. ŞÜKRÜ NAİL GÜNER 7
  8. İSMAİL REİSLİ 8
  9. SEVGİ KELEŞ 9